Table 1. Association between HSP90 expression and clinicopathological characteristics of patients.
| Characteristics | Total cases (%) | HSP90 expression | P-value | |
|---|---|---|---|---|
| Low (%) | High (%) | |||
| Gender | 0.223 | |||
| Male | 54 (54.5%) | 27 (50.0%) | 27 (50.0%) | |
| Female | 45 (45.5%) | 17 (37.8%) | 28 (62.2%) | |
| Age (year) | 0.438 | |||
| <65 | 31 (31.3%) | 12 (38.7%) | 19 (61.3%) | |
| ≥65 | 68 (68.7%) | 32 (47.1%) | 36 (52.9%) | |
| Location | 0.604 | |||
| Ascending colon | 35 (35.4%) | 17 (48.6%) | 18 (51.4%) | |
| Transverse colon | 25 (25.3%) | 9 (36.0%) | 16 (64.0%) | |
| Descending-Sigmoid colon | 39 (39.4%) | 18 (46.2%) | 21 (53.8%) | |
| T category | 0.505 | |||
| T1 + T2 | 10 (10.1%) | 3 (30.0%) | 7 (70.0%) | |
| T3 + T4 | 89 (89.9%) | 41 (46.1%) | 48 (53.9%) | |
| N category | 0.608 | |||
| N0 | 59 (59.6%) | 27 (45.8%) | 32 (54.2%) | |
| N1 | 29 (29.3%) | 11 (37.9%) | 18 (62.1%) | |
| N2 | 11 (11.1%) | 6 (54.5%) | 5 (45.5%) | |
| Differentiation | 0.621 | |||
| Well to moderate | 49 (49.5%) | 23 (46.9%) | 26 (53.1%) | |
| Low | 50 (50.5%) | 21 (42.0%) | 29 (58.0%) | |
| AJCC stage | 0.749 | |||
| I, II | 59 (59.6%) | 27 (45.8%) | 32 (54.2%) | |
| III, IV | 40 (40.4%) | 17 (42.5%) | 23 (57.5%) | |
| Overall survival | 0.039 | |||
| Death | 59 (59.6%) | 21 (35.6%) | 38 (64.4%) | |
| Alive | 40 (40.4%) | 23 (57.5%) | 17 (42.5%) | |